Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period
Blood
.
2019 Oct 31;134(18):1558-1561.
doi: 10.1182/blood.2019001728.
Authors
Gunnar Juliusson
1
2
,
Oskar Hagberg
3
,
Vladimir Lj Lazarevic
1
,
Emma Ölander
4
,
Petar Antunovic
5
,
Jörg Cammenga
6
,
Lovisa Wennström
7
,
Lars Möllgård
7
,
Mats Brune
7
,
Martin Jädersten
8
,
Stefan Deneberg
8
,
Sören Lehmann
8
9
,
Åsa Rangert Derolf
8
,
Martin Höglund
9
10
Affiliations
1
Department of Hematology, Skåne University Hospital, Lund, Sweden.
2
Stem Cell Center, Department of Laboratory Medicine, and.
3
Department of Cancer Epidemiology, Lund University, Lund, Sweden.
4
Department of Hematology, Sundsvall Hospital, Sundsvall, Sweden.
5
Department of Hematology, Linköping University Hospital, Linköping, Sweden.
6
Department of Hematology, Linköping University, Linköping, Sweden.
7
Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
8
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
9
Department of Medical Sciences, Uppsala University, Uppsala, Sweden; and.
10
Division of Hematology, Uppsala University Hospital, Uppsala, Sweden.
PMID:
31515252
PMCID:
PMC6839949
DOI:
10.1182/blood.2019001728
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Aged
Female
Humans
Leukemia, Myeloid, Acute / mortality*
Male
Middle Aged
Sex Factors
Survival Rate
Sweden / epidemiology